Clinical Trials Browser

Hormone Refractory Prostate Cancer × sargramostim × Clear all

NCT00313482 2012-05-11

PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC

Phase 2 Terminated

Hormone Refractory Prostate Cancer